Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jeffrey Tosoian MD, MPH

Jeffrey J. Tosoian MD, MPH

Assistant Professor of Urology, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN

Jeffrey J. Tosoian, MD, MPH, is an Assistant Professor of Urology at the Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center. He completed medical school and urology residency at Johns Hopkins, where he obtained an MPH in epidemiological and biostatistical methods for clinical research. He then completed a translational research and clinical fellowship in urologic oncology at the University of Michigan. Dr. Tosoian’s research is focused on the development and clinical application of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide detection and management of genitourinary cancers.

Disclosures

Dr. Tosoian is a co-founder of LynxDx, Inc.

Recent Contributions to PracticeUpdate:

  1. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the US
  2. AUA 2019: Observations From Dr. Jeffrey Tosoian
  3. ASCO GU 2019: General Session 1: Observations From Dr. Jeffrey Tosoian
  4. ASCO GU 2019: General Session 2: Observations From Dr. Jeffrey Tosoian
  5. Active Surveillance of Prostate Cancer Is a Viable Option in Younger Men
  6. PSA Kinetics Predicts Prostate Cancer Active Surveillance Outcomes
  7. PSA Recurrence After EBRT + ADT
  8. Mortality Similar for Prostatectomy and Observation for Early Prostate Cancer
  9. The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer
  10. Treatment Considerations for Oligometastatic Prostate Cancer

Elsewhere

Most Read This Week

Recently Updated